Afișare rezultate
Afisarea articolelor 1-1(1) pentru cuvîntul-cheie "
disease–drug interaction"
Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis |
Khalilieh Sauzanne1, Hussain Azher1, Montgomery Diana1, Levine Vanessa1, Shaw Peter Martin1, Bodrug Inga2, Mekokishvili Lally3, Bailey-Smith Candice1, Glasgow Xiaoli Shirley1, Cheng Amy1, Martinho Monika1, Iwamoto Marian1 |
|
British Journal of Clinical Pharmacology |
Nr. / 2018 / ISSN 0306-5251 |
Disponibil online 5 December, 2018. Descarcări-0. Vizualizări-767 |
-----------------------------------------------------------------------------------------------------------------------------------
1-1 of 1